Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 68, Issue 4, 2008, Pages 270-276

  Schroll, S ^a   Arzt, M ^a   Sebah, D ^a   Stoelcker, B ^a   Luchner, A ^a   Budweiser, S ^b   Blumberg, F C ^a,c   Pfeifer, M ^a,b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Lungenklinik Donaustauf ^*  (Germany)

^c PROSPER HOSPITAL   (Germany)

Author keywords

Ambrisentan; Bosentan; Monocrotaline; Prostacyclin synthase; Pulmonary hypertension

Indexed keywords

AMBRISENTAN; BOSENTAN; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; MESSENGER RNA; MONOCROTALINE; PROSTACYCLIN SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HEART RIGHT VENTRICLE HYPERTROPHY; IMMUNOHISTOCHEMISTRY; LUNG HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART VENTRICLES; HEMODYNAMICS; HYPERTENSION, PULMONARY; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; INTRAMOLECULAR OXIDOREDUCTASES; LUNG; MALE; ORGAN SIZE; PHENYLPROPIONATES; PULMONARY ARTERY; PYRIDAZINES; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONAMIDES;

ANIMALIA; RATTUS;

EID: 46949088789     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510701673375     Document Type: Article

References (29)

1. D'Alonzo G, Barst R, Ayres S, Bergofsky E, Brundage B, Detre K. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991;115:343-9.
2. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327:70-5.
3. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004;351:1655-65.
4. Seo B, Oemar BS, Siebenmann R, von Segesser L, Luscher TF. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994;89:1203-8.
5. Zamora M, Dempsey EC, Stelzner TJ. BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol, 1993;429-33.
6. Hirata Y, Emori T, Eguchi S, Kanno., Imai T, Ohta K. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993;4:1367-73.
7. Lee SH, Rubin LJ. Current treatment strategies for pulmonary arterial hypertension. J Intern Med 2005;258:199-215.
8. Motte S, McEntee K, Naeije R. Endothelin receptor antagonists. Pharmacol Ther 2006;110:386-414.
9. Galie N, Badesch D, Oudiz R, Simonneau G, McGoon MD, Keogh AM. Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2005;46:529-35.
10. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346:896-903.
11. Blumberg FC, Wolf K, Sandner P, Lorenz C, Riegger GAJ, Pfeifer M. The NO donor molsidomine reduces endothelin-1 gene expression in chronic hypoxic rat lungs. Am J Physiol Lung Cell Mol Physiol 2001;280:L258-63.
12. Remmele W, Hildebrand U, Hienz HA, Klein PJ, Vierbuchen M, Behnken LtJ. Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch 1986;409:127-47.
13. Tuder RM, Cool CD, Geraci MW, Wang J, Abman SH, Wright L. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am J Respir Crit Care Med 1999;159:1925-32.
14. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-36.
15. Okahara K, Sun B, Kambayashi J. Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells. Arterioscler Thromb Vasc Biol 1998;18:1922-6.
16. Blumberg FC, Lorenz C, Wolf K, Sandner P, Riegger GAJ, Pfeifer M. Increased pulmonary prostacyclin synthesis in rats with chronic hypoxic pulmonary hypertension. Cardiovasc Res 2002;55:171-7.
17. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002;106:1477-82.
18. Olschewski H, Simonneau G, Galie N, Higenbottam T, Naeije R, Rubin LJ. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002;347:322-9.
19. Hoshikawa Y, Voelkel NT, Gesell TL, Mark MD, Morris KG, Alger LA. Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. Am J Respir Crit Care Med 2001;164:314-18.
20. Ivy D, McMurtry IF, Colvin K, Imamura M, Oka M, Lee DS. Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension. Circulation 2005;111:2988-96.
21. Ivy D, Yanagisawa M, Gariepy CE, Gebb SA, Colvin KL, McMurtry IF. Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats. Am J Physiol Lung Cell Mol Physiol 2002;282:L703-12.
22. Bauer M, Wilkens H, Langer F, Schneider SO, Lausberg H, Schafers HJ. Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension. Circulation 2002;105:1034-6.
23. Ivy D, Parker TA, Abman SH. Prolonged endothelin B receptor blockade causes pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 2000;279:L758-65.
24. Jasmin JF, Lucas M, Cernacek P, Dupuis J. Effectiveness of a nonselective ET(A/B) and a selective ET(A) antagonist in rats with monocrotaline-induced pulmonary hypertension. Circulation 2001;103:314-18.
25. D'Orleans-Juste P, Labonte J, Bkaily G, Choufani S, Plante M, Honore JC. Function of the endothelin(B) receptor in cardiovascular physiology and pathophysiology. Pharmacol Ther 2002;95:221-38.
26. Nishida M, Okada Y, Akiyoshi K, Eshiro K, Takaoka M, Gariepy CE. Role of endothelin ETB receptor in the pathogenesis of monocrotaline-induced pulmonary hypertension in rats. Eur J Pharmacol 2004;496:159-65.
27. Soma S, Takahashi H, Muramatsu M, Oka M, Fukuchi Y. Localization and distribution of endothelin receptor subtypes in pulmonary vasculature of normal and hypoxia-exposed rats. Am J Respir Cell Mol Biol 1999;20:620-30.
28. Takahashi H, Soma S, Muramatsu M, Oka M, Ienaga H, Fukuchi Y. Discrepant distribution of big endothelin (ET)-1 and ET receptors in the pulmonary artery. Eur Respir J 2001;18:5-14.
29. Schiffrin EL, Touyz RM. Vascular biology of endothelin. J Cardiovasc Pharmacol 1998;32 Suppl 3:S2-13.